General Biologic, Feb 2012
SOURCE SELECT is China's premier newswire, research tool, and customizable product tracking system dedicated to the pharmaceutical and biotechnology industry. This online and email alert service
JZMed Inc., July 2008, Pages: 162
, Western pharma/biotech companies would have found themselves in the end that they have missed what is available presently in China if they decided to wait until all issues they are concerned
Financial Intelligence Services Limited (World Vest Base), Feb 2012, Pages: 1
financial advisor to see if it is appropriate for you.
CHINABIOTECH - World'Vest Base Business Risk
Financial Intelligence Services Limited (World Vest Base), Feb 2012, Pages: 1
for statistical black swans as past history is not a guarantee of continuation or reliability in the present or future. Speak to your financial advisor to see if it is appropriate for you.
CHINABIOTECH
Financial Intelligence Services Limited (World Vest Base), Feb 2012, Pages: 1
financial advisor to see if it is appropriate for you.
CHINA SXAN BIOTECH - World'Vest Base Business Risk
Financial Intelligence Services Limited (World Vest Base), Feb 2012, Pages: 1
for statistical black swans as past history is not a guarantee of continuation or reliability in the present or future. Speak to your financial advisor to see if it is appropriate for you.
CHINA SXAN BIOTECH
Financial Intelligence Services Limited (World Vest Base), Feb 2012, Pages: 1
financial advisor to see if it is appropriate for you.
CHINABIOTECH - World'Vest Base Dossier
Financial Intelligence Services Limited (World Vest Base), Feb 2012, Pages: 1
financial advisor to see if it is appropriate for you.
CHINA SXAN BIOTECH - World'Vest Base Dossier
Business Insights, Feb 2010, Pages: 137
and disadvantages.
- More than 10 case studies that illustrate biotech tech transfer best practices.
- Comprehensive discussion of offshore biotech tech transfer, particularly focusing on India and China.
Scope
Decision Resources, Inc., June 2010, Pages: 33
After the disastrous stock market crash of 2008 and ensuing global economic crisis, the biotech industry is showing some signs of recovery. In 2009, overall fundraising was up and corporate
Global Industry Analysts, Inc., Jan 2011, Pages: 115
Laboratory (India)
Shandong Jingpeng Bio-Pesticide Co, Ltd (China)
Som Phytopharma India Ltd (India)
Sri Biotech (India)
Sujanil Chemo Industries (India)
Sumitomo Chemical Co, Ltd (Japan)
Super
Burrill & Company, March 2010, Pages: 400
.28 Select Australian Biotech M&A in 2009
Figure 6.29 Select Australian Partnering Deals in 2009
Figure 6.30 Top Ten Australian Biotech Companies (September 30, 2009)
China
Figure 6.31 Significant
Global Industry Analysts, Inc., April 2011, Pages: 402
and niche players such as Advanced Enzymes Technologies Ltd., Ajeet Seeds Ltd., Anthem BioSciences Pvt. Ltd., Bharat Biotech International Limited, Bharat Serums and Vaccines Ltd., Biocon Limited, Syngene
Universal Medica, Feb 2012, Pages: 3
-marketing expert team based in china, "Chinese Pharma & Biotech Press Review" is a strategic tool which delivers the qualified information to foresee the marketing opportunities.
Coming from various
Bioplan Associates Inc., Jan 2008, Pages: 766
their roots back several thousand years through schools of healing practice. The Indian government is actively developing that experience into a sound biotech industry. We cover Indian government policies
GlobalData, Nov 2010, Pages: 34
Clinical Trials Of Its Cell Culture H1N1 Vaccine HN-VAC
Sep 30, 2009: Bharat Biotech Secures Patent Rights In US, Europe, China, Australia And Other Nations For Lysostaphin
May 28, 2008: Bharat Biotech
Global Markets Direct, Nov 2010, Pages: 34
, China, Australia And Other Nations For Lysostaphin
May 28, 2008: Bharat Biotech Announces Successful Completion Of Its Phase I/II Trial For 116E Rotavirus Vaccine
Feb 13, 2006: Bharat Biotech
Bizacumen Inc., Nov 2009, Pages: 247
- In the Shadow of Developed Nations
Biotech Research Initiatives
Asia-Pacific Markets - Keen to Enter Agricultural
Biotechnology Field
China - Rapidly Embracing Biotechnology
India - Biotechnology on Priority
